BayMed Venture Partners
Overview
BayMed Venture Partners is a venture capital firm focused on early-stage medical device and digital health companies in North America and Israel. They identify and mentor innovative maturing companies to advance breakthrough solutions that deliver value for their portfolio companies, investment partners, and the global healthcare system.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| AtaCor Medical | Oct 2025 | Financing | Co-investor |
| Deep Blue Medical Advances | Jun 2022 | Series A Extension | Lead |
| Append Medical | Jul 2023 | Series A Extension | - |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is BayMed Venture Partners based?
BayMed Venture Partners is headquartered in San Francisco, California, United States.
When was BayMed Venture Partners founded?
BayMed Venture Partners was founded in 2020.
How many portfolio companies does BayMed Venture Partners have?
BayMed Venture Partners has 4 portfolio companies in Caplight's dataset.
What are some companies in BayMed Venture Partners's portfolio?
Portfolio companies visible on Caplight include AtaCor Medical, Deep Blue Medical Advances, Append Medical.
What was BayMed Venture Partners's most recent investment shown here?
BayMed Venture Partners's most recent investment in this portfolio sample was in AtaCor Medical in 2025.
What sectors does BayMed Venture Partners focus on?
BayMed Venture Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does BayMed Venture Partners focus on?
Stage focus information for BayMed Venture Partners is not publicly available.
What is BayMed Venture Partners's AUM?
BayMed Venture Partners's assets under management are estimated between $0.0 and $50.0M.